Progress of rare epidermal growth factor receptor mutations in non-small cell lung cancer
10.3760/cma.j.cn115355-20201213-00703
- VernacularTitle:非小细胞肺癌中表皮生长因子受体罕见突变的研究进展
- Author:
Xiaofang ZHANG
1
;
Jinfang ZHAI
;
Weihua YANG
Author Information
1. 山西医科大学研究生院，太原 030001
- Keywords:
Carcinoma, non-small-cell lung;
Receptor, epidermal growth factor;
Rare mutations
- From:
Cancer Research and Clinic
2021;33(7):553-556
- CountryChina
- Language:Chinese
-
Abstract:
With the development of biomolecular diagnostic technology and genetic analysis, it has been gradually discovered that some gene abnormalities can drive the occurrence and development of lung cancer. Among them, epidermal growth factor receptor (EGFR) is the most common mutant gene in non-small cell lung cancer (NSCLC). However, most of the current researches focus on the common mutations of EGFR, such as exon 19 deletion (19del) and exon 21 point mutation (L858R). There are few studies on rare EGFR mutations. This article reviews the progress of rare EGFR mutations in NSCLC.
